A new drug application (NDA) has been submitted to the FDA seeking approval of rusfertide, an investigational hepcidin ...

For individuals facing fear, uncertainty and repeated procedures associated with recurrent low-grade intermediate-risk bladder tumors, timely access to treatment can be critical. ZUSDURI, the first ...

Myeloid leukaemia is a cancer that begins not in a bone or an organ, but deep inside the marrow of the bones, the factory ...

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has revolutionized how physicians treat cancer, especially blood cancers. “These patients can be cured ...

Objectives To investigate associations between daily physical activity, activity intensity and step counts with incident cancer risk. Methods Prospective analysis of UK Biobank participants who wore ...

Guardant Health is touting the results of a new study showing its Reveal blood test can detect whether chemotherapy is failing months before evidence shows up on regular scans, allowing oncologists to ...

DEAR DR. ROACH: My husband was diagnosed with chronic lymphocytic leukemia (CLL) in 2010 and remained in stage 2 with no effects until 2022. In the interim, he was also diagnosed with atrial ...

A common vaccine could help to fight cancer, a new study suggests. For cancer patients undergoing immunotherapy, researchers found that receiving the mRNA COVID-19 vaccine within about 100 days of ...

John Middleton of North Carolina has been told without a liver transplant, he likely has about 18 months to live. His doctor has recommended a treatment that he says would give John the best chance of ...

WASHINGTON (AP) — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune systems to help fight tumors. People with advanced lung or skin ...

A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy lived dramatically longer than those who didn’t. Researchers from the ...